NCT03692455

Brief Summary

This study represents a long-term observational follow-up of patients who had previously undergone bariatric surgery (laparoscopic sleeve gastrectomy or Roux-en-Y gastric bypass) in the context of an earlier interventional trial (NCT03692455). No new interventions are assigned in the follow-up phase. Participants are evaluated clinically and functionally at predefined intervals using standardized multimodal assessments (symptom questionnaires, endoscopy, manometry, radiology, and pH monitoring).

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
75

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 21, 2015

Completed
2.8 years until next milestone

First Posted

Study publicly available on registry

October 2, 2018

Completed
7 years until next milestone

Study Start

First participant enrolled

September 17, 2025

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 17, 2025

Completed
22 days until next milestone

Study Completion

Last participant's last visit for all outcomes

November 8, 2025

Completed
Last Updated

September 25, 2025

Status Verified

September 1, 2025

Enrollment Period

1 month

First QC Date

December 21, 2015

Last Update Submit

September 22, 2025

Conditions

Keywords

GERDRoux-en-Y Gastric BypassVertical Sleeve GastrectomyLion 2.0 Consensus

Outcome Measures

Primary Outcomes (1)

  • Change in number of Participants With Gastroesophageal Reflux Disease (GERD)

    Prevalence of GERD in patients will be characterized according to Lyon 2.0 consensus

    8 years after intervention

Secondary Outcomes (6)

  • Change in number of Participants Presenting GERD symptoms

    8 years after intervention

  • Change in number of Participants With Esophageal Injury

    8 years after intervention

  • Change in Total Esophageal Acid Exposure at 24h pH Monitoring

    8 years after intervention

  • Change in Esophageal Acid Exposure at 24h pH Monitoring in Upright Position

    8 years after intervention

  • Change in Esophageal Acid Exposure at 24h pH Monitoring in Supine Position

    8 years after intervention

  • +1 more secondary outcomes

Study Arms (2)

LRSYGP Group

Patients will undergo Clinical evaluation and Exams, 8 years after Laparoscopic Roux-Y Gastric Bypass.

LSG group

Patients will undergo Clinical evaluation and Exams 8 years after Laparoscopic Sleeve Gastrectomy.

Eligibility Criteria

Age18 Years - 78 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

This study represents a long-term observational follow-up of 75 patients who had previously undergone bariatric surgery (laparoscopic sleeve gastrectomy or Roux-en-Y gastric bypass) in the context of an earlier interventional trial (NCT03692455). No new interventions are assigned in the follow-up phase. Participants are evaluated clinically and functionally at predefined intervals using standardized multimodal assessments (symptom questionnaires, endoscopy, manometry, radiology, and pH monitoring).

You may qualify if:

  • Patients enrolled in a previous prospective dual-cohort extension with 75 patients of the original Trial.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gastrobese Clinic

Passo Fundo, Rio Grande do Sul, 99010-112, Brazil

Location

MeSH Terms

Conditions

Gastroesophageal RefluxObesity, Morbid

Condition Hierarchy (Ancestors)

Esophageal Motility DisordersDeglutition DisordersEsophageal DiseasesGastrointestinal DiseasesDigestive System DiseasesObesityOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Richard R Gursky, PhD

    Federal University of Rio Grande do Sul

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Director

Study Record Dates

First Submitted

December 21, 2015

First Posted

October 2, 2018

Study Start

September 17, 2025

Primary Completion

October 17, 2025

Study Completion

November 8, 2025

Last Updated

September 25, 2025

Record last verified: 2025-09

Locations